Kevin’s Inaugural Lecture as Chair of Chemical Nanotechnology 02 May 2019

Kevin’s Inaugural Lecture as Chair of Chemical Nanotechnology 02 May 2019

May 27, 2019 – 8:43 pm

Thanks to all for attending my Inaugural Lecture. Great to share with family, current group members, former group members and colleagues. Click on picture...

Just published in Chemical Reviews: Coughlan et al Compound Copper Chalcogenide Nanocrystals

Just published in Chemical Reviews: Coughlan et al Compound Copper Chalcogenide Nanocrystals

April 11, 2017 – 9:38 am

Compound Copper Chalcogenide Nanocrystals   Link to paper Claudia Coughlan†, Maria Ibáñez‡, Oleksandr Dobrozhan‡§ , Ajay Singh∥, Andreu Cabot*‡⊥, and Kevin M. Ryan*† †...

Just accepted in Cryst Eng Comm: Sheehan et al, The selective synthesis of nickel germanide

Just accepted in Cryst Eng Comm: Sheehan et al, The selective synthesis of nickel germanide

March 31, 2017 – 11:06 am

Martin Sheehan,ab Yina Guo,a Grace Flynn,a Hugh Geaneya and Kevin M. Ryan *ab We report the formation of NiGe nanowires by the thermal decomposition...

Group Research features on RTE programme ECO-EYE

Group Research features on RTE programme ECO-EYE

February 11, 2016 – 10:35 am

Dr Kevin Ryan and Dr Claudia Coughlan featured onRTE 1 TV 09/02/16  on the “Eco Eye” programme.  “Science communicator Dr Lara Dungan will take a...

Latest Entries

Advance Articles: Just Accepted Papers

Just Accepted in Crystal Growth and Design: Controlling Polymorphism of Carbamazepine Nanoparticles in a Continuous Supercritical CO2-Assisted Spray Drying Process

Just Accepted in Crystal Growth and Design: Controlling Polymorphism of Carbamazepine Nanoparticles in a Continuous Supercritical CO2-Assisted Spray Drying Process

Controlling Polymorphism of Carbamazepine Nanoparticles in a Continuous Supercritical CO2-Assisted Spray Drying Process https://doi.org/10.1021/acs.cgd.9b00154 Barry Long, Gavin Walker,  Kevin M Ryan, Luis Padrela Abstract Controlling polymorphism in the transition from batch to continuous crystallization represents a major obstacle for the pharmaceutical industry. This work demonstrates a novel methodology to control the polymorphism of carbamazepine (CBZ) […]